Human medicines European public assessment report (EPAR): Synagis, palivizumab, Respiratory Syncytial Virus Infections, Date of authorisation: 13/08/1999, Revision: 46, Status: Authorised
Human medicines European public assessment report (EPAR): Jcovden (previously COVID-19 Vaccine Janssen), COVID-19 vaccine (Ad26.COV2-S [recombinant]), COVID-19 virus infection, Date of authorisation: 11/03/2021, Revision: 30, Status: Authorised
Human medicines European public assessment report (EPAR): Lyfnua, gefapixant, Cough, Date of authorisation: 15/09/2023, Status: Authorised
Herbal medicinal product: Pruni cerasi stipites, Pruni cerasi stipites, D: Draft under discussion
Herbal medicinal product: Species pectoralis, Combination: Species pectoralis, D: Draft under discussion
Herbal medicinal product: Cannabis flos, Cannabis flos, D: Draft under discussion
EudraVigilance support guide
Human medicines European public assessment report (EPAR): Cabometyx , cabozantinib, Carcinoma, Renal Cell;Carcinomas, Hepatocellular, Date of authorisation: 09/09/2016, Revision: 18, Status: Authorised
Resources for healthcare professionals
Iodixanol: List of nationally authorised medicinal products - PSUSA/00001766/202004